

Can't find Amphetamine/Dextroamphetamine (Adderall)? Learn about alternative ADHD medications including Vyvanse, Ritalin, Dexedrine, and Strattera.
If you've been trying to fill your Amphetamine/Dextroamphetamine prescription and keep running into empty shelves, you're not imagining things. The shortage that began in late 2022 is still affecting patients in 2026, and for many people, the question has shifted from "when will this end?" to "what else can I take?"
The good news is that there are several effective alternatives to Amphetamine/Dextroamphetamine. The right one for you depends on your symptoms, medical history, and how your body responds to different medications. This guide covers the most common options so you can have an informed conversation with your doctor.
Important: Never switch medications on your own. Always work with your prescriber to find the safest and most effective alternative for your situation.
Amphetamine/Dextroamphetamine — sold under brand names like Adderall and Adderall XR — is a central nervous system stimulant that treats ADHD and narcolepsy. It contains a combination of amphetamine salts (75% dextroamphetamine and 25% levoamphetamine) that increase dopamine and norepinephrine levels in the brain.
These neurotransmitters play key roles in focus, attention, and impulse control. By boosting their availability, Amphetamine/Dextroamphetamine helps people with ADHD manage their symptoms throughout the day.
For a deeper dive, read: How Does Amphetamine/Dextroamphetamine Work? Mechanism of Action Explained.
Vyvanse is one of the closest alternatives to Adderall. It's a prodrug, meaning it's inactive until your body converts it into dextroamphetamine after you swallow it. This gives it a smoother onset and may reduce the "crash" some people experience with Adderall.
Vyvanse is often the first alternative doctors consider when Adderall isn't available, since it's in the same amphetamine family.
Methylphenidate is the other major class of stimulant used to treat ADHD. While it works on the same neurotransmitters (dopamine and norepinephrine), it has a different mechanism — it primarily blocks reuptake rather than increasing release, as amphetamines do.
If you've never tried Methylphenidate, it's definitely worth discussing with your doctor. Some patients respond better to it than to amphetamines, and vice versa.
Dexedrine contains only the dextro-isomer of amphetamine (unlike Adderall, which has both dextro- and levo-amphetamine). Some patients find that pure Dextroamphetamine produces fewer side effects, particularly less anxiety and jitteriness.
Since Dextroamphetamine is a different formulation, it may have different availability during the shortage. It's worth checking.
Strattera is a non-stimulant option for ADHD treatment. It's a selective norepinephrine reuptake inhibitor (SNRI) that works differently from stimulants. Because it's not a controlled substance, it doesn't face the same DEA production limits or shortage issues.
Atomoxetine is a particularly good option for patients who have a history of substance use disorder or who cannot tolerate stimulants.
If you're considering an alternative, here are some tips for a productive conversation with your prescriber:
Not being able to fill your ADHD medication is stressful and disruptive. But you have options. Whether it's Vyvanse, Methylphenidate, Dexedrine, or a non-stimulant like Strattera, there are proven alternatives that can help you manage your symptoms while the Amphetamine/Dextroamphetamine shortage continues to resolve.
Start by checking Medfinder to see if your current medication is available near you. If it's not, use this guide to start a conversation with your doctor about what's next.
Related articles:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.